What's new? Log in Free sign up

Trinity Biotech (TRIB)

Company Profile

Company profile

Ticker

TRIB

Exchange

Website

www.trinitybiotech.com

CEO

Mr. John Gillard

Incorporated

Location

Fiscal year end

Industry (SIC)

In Vitro & In Vivo Diagnostic Substances

Ortho Clinical Diagnostics • QuidelOrtho • IDEXX Laboratories • Myriad Genetics • Neogen • Celldex Therapeutics • Lantheus • Meridian Bioscience • Lucira Health • Heska Corp. ...

Former names

RURBAN FINANCIAL CORP

SEC CIK

Corporate docs

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

TRIB stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Fourth Amended and Restated Credit Agreement and Guaranty

Current report (foreign)

Current report (foreign)

Current report (foreign)

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal

Current report (foreign)

Prospectus supplement for primary offering

Third Amended and Restated Credit Agreement and Guaranty

Trinity Biotech Receives Early Approval from the World Health

Current report (foreign)

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

PERCEPTIVE ADVISORS LLC

New Main Equity Co., Ltd.

MiCo IVD Holdings, LLC

PERCEPTIVE ADVISORS LLC

PERCEPTIVE ADVISORS LLC

PERCEPTIVE ADVISORS LLC

MiCo IVD Holdings, LLC

STONEHILL CAPITAL MANAGEMENT LLC

RENAISSANCE TECHNOLOGIES LLC

Financial summary

Financial statements Chart TRIB financial data

Quarter (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q3 2024

TRIB institutional ownership history Ownership history

63.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	15	16	-6.3%
Opened positions	4	9	-55.6%
Closed positions	5	1	+400.0%
Increased positions	2	1	+100.0%
Reduced positions	2	0	NEW

13F shares	Current	Prev Q	Change
Total value	365.04 mm	777.50 mm	-53.0%
Total shares	47.65 mm	103.63 mm	-54.0%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
MiCo IVD	46.29 mm	$23.15 mm	0.0%
Whitefort Capital Master Fund	585.57 k	$2.23 mm	0.0%
Hunter Associates Investment Management	359.81 k	$390.00 k	+7.8%
Renaissance Technologies	250.15 k	$275.17 mm	-5.8%
Acadian Asset Management	41.84 k	$46.00 k	-42.0%
HRT Financial	34.03 k	$37.00 k	NEW
Moss Adams Wealth Advisors	25.67 k	$28.23 mm	0.0%
Cambridge Investment Research Advisors	22.28 k	$25.00 k	0.0%
Becker Capital Management	18.00 k	$19.80 mm	NEW
Inspirion Wealth Advisors	10.00 k	$11.00 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Perceptive Advisors	0.00	-56.00 mm	EXIT
HRT Financial	34.03 k	+34.03 k	NEW
Acadian Asset Management	41.84 k	-30.27 k	-42.0%
Hunter Associates Investment Management	359.81 k	+26.10 k	+7.8%
Becker Capital Management	18.00 k	+18.00 k	NEW
Renaissance Technologies	250.15 k	-15.30 k	-5.8%
Virtu Financial	0.00	-14.27 k	EXIT
Redwood Wealth Management	0.00	-2.03 k	EXIT
SJS Investment Consulting	2.00 k	+2.00 k	NEW
Rhumbline Advisers	1.81 k	+1.44 k	+385.8%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

Trinity Biotech's Latest CGM Trial Sets New Benchmark For Accuracy, Reliability, And User Experience

The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than 50% improvement in

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

What's Going On With Trinity Biotech Shares Tuesday?

Press releases

From Benzinga Pro

Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology

DUBLIN, Ireland, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable

Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial

DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today

Stocks Under $2 to Watch in February 2025: TRIB, MODD, PNPN.V, BACK – More Inside!

As we move into February 2025, savvy investors are turning their attention to affordable stocks with strong growth potential, particularly those under $2. These low-cost opportunities often deliver outsized returns,

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.